111 Operating Margin 2018-2025 | YI
Current and historical operating margin for 111 (YI) over the last 10 years. The current operating profit margin for 111 as of September 30, 2025 is -0.52%.
| 111 Operating Margin Historical Data | |||
|---|---|---|---|
| Date | TTM Revenue | TTM Operating Income | Operating Margin |
| 2025-09-30 | $1.86B | $0.00B | -0.05% |
| 2025-06-30 | $1.95B | $0.00B | -0.05% |
| 2025-03-31 | $1.97B | $0.00B | -0.05% |
| 2024-12-31 | $1.97B | 0 | 0.00% |
| 2024-09-30 | $2.06B | $-0.03B | -1.36% |
| 2024-06-30 | $2.05B | $-0.04B | -1.91% |
| 2024-03-31 | $2.06B | $-0.05B | -2.19% |
| 2023-12-31 | $2.11B | $-0.05B | -2.33% |
| 2023-09-30 | $2.09B | $-0.03B | -1.63% |
| 2023-06-30 | $2.05B | $-0.03B | -1.66% |
| 2023-03-31 | $2.03B | $-0.04B | -1.97% |
| 2022-12-31 | $1.96B | $-0.05B | -2.71% |
| 2022-09-30 | $1.96B | $-0.06B | -2.91% |
| 2022-06-30 | $2.01B | $-0.07B | -3.64% |
| 2022-03-31 | $2.02B | $-0.09B | -4.45% |
| 2021-12-31 | $1.95B | $-0.10B | -5.13% |
| 2021-09-30 | $1.84B | $-0.11B | -5.82% |
| 2021-06-30 | $1.67B | $-0.10B | -5.87% |
| 2021-03-31 | $1.43B | $-0.08B | -5.73% |
| 2020-12-31 | $1.26B | $-0.07B | -5.72% |
| 2020-09-30 | $0.99B | $-0.07B | -7.14% |
| 2020-06-30 | $0.80B | $-0.07B | -8.74% |
| 2020-03-31 | $0.69B | $-0.07B | -10.39% |
| 2019-12-31 | $0.57B | $-0.07B | -12.68% |
| 2019-09-30 | $0.45B | $-0.07B | -14.99% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Information Systems | $0.044B | $1.973B |
| 111, Inc. operates as a digital and mobile healthcare platform. The Company offers pharmacy distribution, medical consultancy, e-prescription and other services. 111, Inc. is headquartered in Shanghai, China. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Veeva Systems (VEEV) | United States | $36.493B | 42.21 |
| Tempus AI (TEM) | United States | $11.621B | 0.00 |
| Doximity (DOCS) | United States | $7.649B | 31.50 |
| Hims & Hers Health (HIMS) | United States | $6.743B | 54.85 |
| IRhythm Holdings (IRTC) | United States | $5.166B | 0.00 |
| Hinge Health (HNGE) | United States | $3.350B | 0.00 |
| Privia Health (PRVA) | United States | $2.945B | 184.15 |
| 10x Genomics (TXG) | United States | $2.832B | 0.00 |
| Heartflow (HTFL) | United States | $2.739B | 0.00 |
| Inspire Medical Systems (INSP) | United States | $2.307B | 38.17 |
| Omnicell (OMCL) | United States | $2.257B | 46.15 |
| Azenta (AZTA) | United States | $1.842B | 75.57 |
| Clover Health Investments (CLOV) | United States | $1.338B | 0.00 |
| Enovis (ENOV) | United States | $1.316B | 6.91 |
| Schrodinger (SDGR) | United States | $1.210B | 0.00 |
| Butterfly Network (BFLY) | United States | $1.139B | 0.00 |
| Phreesia (PHR) | United States | $0.955B | 0.00 |
| Fulgent Genetics (FLGT) | United States | $0.860B | 0.00 |
| Talkspace (TALK) | United States | $0.671B | 135.00 |
| Standard BioTools (LAB) | United States | $0.596B | 0.00 |
| Claritev (CTEV) | United States | $0.477B | 0.00 |
| Evolent Health (EVH) | United States | $0.440B | 0.00 |
| SOPHiA GENETICS SA (SOPH) | Switzerland | $0.362B | 0.00 |
| Carlsmed (CARL) | United States | $0.352B | 0.00 |
| Zepp Health (ZEPP) | Netherlands | $0.318B | 0.00 |
| TruBridge (TBRG) | United States | $0.309B | 14.22 |
| Senseonics Holdings (SENS) | United States | $0.299B | 0.00 |
| CapsoVision (CV) | United States | $0.281B | 0.00 |
| KORU Medical Systems (KRMD) | United States | $0.260B | 0.00 |
| Insight Molecular Diagnostics (IMDX) | United States | $0.187B | 0.00 |
| MDxHealth SA (MDXH) | Belgium | $0.179B | 0.00 |
| Nyxoah SA (NYXH) | Belgium | $0.160B | 0.00 |
| Health Catalyst (HCAT) | United States | $0.159B | 0.00 |
| CareCloud (CCLD) | United States | $0.123B | 6.74 |
| Outset Medical (OM) | United States | $0.093B | 0.00 |
| American Well (AMWL) | United States | $0.080B | 0.00 |
| NetraMark Holdings (AINMF) | Canada | $0.077B | 0.00 |
| Pulmonx (LUNG) | United States | $0.076B | 0.00 |
| Retrieve Medical Holdings (RMHI) | United States | $0.067B | 0.00 |
| HeartBeam (BEAT) | United States | $0.062B | 0.00 |
| EUDA Health Holdings (EUDA) | Singapore | $0.059B | 0.00 |
| Precipio (PRPO) | United States | $0.043B | 0.00 |
| Evaxion - (EVAX) | Denmark | $0.034B | 0.00 |
| Lunai Bioworks (LNAI) | United States | $0.021B | 0.00 |
| Predictive Oncology (POAI) | United States | $0.020B | 0.00 |
| P3 Health Partners (PIII) | United States | $0.018B | 0.00 |
| Movano (MOVE) | United States | $0.014B | 0.00 |
| Zhongchao (ZCMD) | China | $0.011B | 0.00 |
| HeartSciences (HSCS) | United States | $0.011B | 0.00 |
| PROFUSA (PFSA) | United States | $0.010B | 0.00 |
| Bullfrog AI Holdings (BFRG) | United States | $0.008B | 0.00 |
| Strata Skin Sciences (SSKN) | United States | $0.007B | 0.00 |
| Tivic Health Systems (TIVC) | United States | $0.002B | 0.00 |
| Healthcare Triangle (HCTI) | United States | $0.002B | 0.00 |
| Mobile-health Network Solutions (MNDR) | Singapore | $0.001B | 0.00 |